Home Cart 0 Sign in  

[ CAS No. 105-50-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 105-50-0
Chemical Structure| 105-50-0
Structure of 105-50-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 105-50-0 ]

Related Doc. of [ 105-50-0 ]

Alternatived Products of [ 105-50-0 ]

Product Details of [ 105-50-0 ]

CAS No. :105-50-0 MDL No. :MFCD00009200
Formula : C9H14O5 Boiling Point : -
Linear Structure Formula :- InChI Key :ZSANYRMTSBBUCA-UHFFFAOYSA-N
M.W : 202.20 Pubchem ID :66045
Synonyms :
Chemical Name :Diethyl 1,3-acetonedicarboxylate

Calculated chemistry of [ 105-50-0 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.67
Num. rotatable bonds : 8
Num. H-bond acceptors : 5.0
Num. H-bond donors : 0.0
Molar Refractivity : 48.15
TPSA : 69.67 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.02 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.13
Log Po/w (XLOGP3) : 0.72
Log Po/w (WLOGP) : 0.46
Log Po/w (MLOGP) : 0.32
Log Po/w (SILICOS-IT) : 1.21
Consensus Log Po/w : 0.97

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.02
Solubility : 19.3 mg/ml ; 0.0957 mol/l
Class : Very soluble
Log S (Ali) : -1.76
Solubility : 3.5 mg/ml ; 0.0173 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.61
Solubility : 5.01 mg/ml ; 0.0248 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 2.03

Safety of [ 105-50-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 105-50-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 105-50-0 ]
  • Downstream synthetic route of [ 105-50-0 ]

[ 105-50-0 ] Synthesis Path-Upstream   1~51

  • 1
  • [ 105-50-0 ]
  • [ 5694-95-1 ]
Reference: [1] Patent: US2011/178043, 2011, A1,
[2] European Journal of Medicinal Chemistry, 2013, vol. 63, p. 907 - 923
[3] Angewandte Chemie - International Edition, 2017, vol. 56, # 39, p. 11816 - 11821[4] Angew. Chem., 2017, vol. 129, # 39, p. 11978 - 11983,6
  • 2
  • [ 105-50-0 ]
  • [ 73027-79-9 ]
Reference: [1] Tetrahedron Letters, 2011, vol. 52, # 4, p. 512 - 514
[2] Patent: WO2014/52365, 2014, A1,
[3] Antimicrobial Agents and Chemotherapy, 2016, vol. 60, # 8, p. 4442 - 4452
  • 3
  • [ 105-50-0 ]
  • [ 6258-28-2 ]
Reference: [1] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1987, vol. 26, p. 341 - 343
  • 4
  • [ 105-50-0 ]
  • [ 40296-46-6 ]
Reference: [1] Tetrahedron Letters, 2011, vol. 52, # 4, p. 512 - 514
[2] Patent: WO2011/97526, 2011, A1,
[3] Patent: WO2013/91011, 2013, A1,
[4] Patent: US8461179, 2013, B1,
[5] Patent: WO2013/184119, 2013, A1,
[6] European Journal of Organic Chemistry, 2014, vol. 2014, # 7, p. 1487 - 1495
[7] Patent: WO2014/52365, 2014, A1,
[8] European Journal of Medicinal Chemistry, 2014, vol. 86, p. 31 - 38
[9] European Journal of Medicinal Chemistry, 2014, vol. 87, p. 52 - 62
[10] Patent: WO2015/38417, 2015, A1,
[11] European Journal of Organic Chemistry, 2014, vol. 2014, # 7, p. 1487 - 1495
[12] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 3, p. 403 - 427
[13] European Journal of Medicinal Chemistry, 2016, vol. 119, p. 17 - 33
[14] Antimicrobial Agents and Chemotherapy, 2016, vol. 60, # 8, p. 4442 - 4452
[15] Patent: WO2007/136465, 2007, A2,
[16] Patent: WO2009/105712, 2009, A1,
[17] Patent: WO2005/34869, 2005, A2,
  • 5
  • [ 122-51-0 ]
  • [ 105-50-0 ]
  • [ 6975-44-6 ]
YieldReaction ConditionsOperation in experiment
81.6%
Stage #1: at 120℃; for 2 h;
Stage #2: With ammonia In water at 0℃; for 1 h;
Diethyl 3-oxopentanedioate (1, 10.00 g, 49.45 mmol), triethyl orthoformate (7.33 g, 49.45 mmol) and acetic anhydride (10.10 g, 98.93 mmol) were combined and stirred at 120 °C for 2 h then allowed to cool to ambient temperature. The volatiles were removed under vacuum. The residue was then cooled in an ice bathand aqueous ammonia (25 mL) was added in portions with stirring. The reaction mixture was stirred at 0 C for 1 h and was then acidified with 2N hydrochloric acid to pH < 5. The precipitate was collected by filtration and allowed to dry to provide 2 as yellowsolid. Yield: 81.6percent. Mp: 207-210 °C. 1H NMR (400 MHz, DMSO-d6,ppm) d: 11.78 (s, br, 1H), 10.74 (s, br, 1H), 8.02 (s, 1H), 5.61 (s, 1H), 4.27 (q, 2H, J 7.1), 1.29 (t, 3H, J 7.1). 13C NMR (100 MHz, DMSOd6,ppm) d: 166.57, 166.40, 164.00, 142.97, 100.44, 98.96, 61.35, 14.46.
55.7%
Stage #1: at 130℃; for 3 h;
Stage #2: With ammonium hydroxide In water at 20℃; for 0.5 h;
Step 1:
Preparation of ethyl 4,6-dihydroxy-5-nitronicotinate (14)
A mixture of diethyl 1,3-acetonedicarboxylate (80.0 g, 0.40 mol), acetic anhydride (80.8 g, 0.79 mol) and ethyl orthoformate (59.2 g, 0.40 mol) was heated to 130 °C for 3 h.
Volatile components were removed under reduced pressure and the remaining mixture was treated with aqueous ammonia 160 ml.
The resulting mixture was stirred for another 30 min at ambient temperature.
Subsequently the pH of the mixture was adjusted to 2 with 6 mol/L hydrochloric acid aqueous.
The solid was filtered off, washed with cold water and dried in vacuum overnight.
Toluene (120 ml) was then added to the crude product before the mixture was stirred at 0 °C for 30 min, filtered and dried to give 14 40.4 g as red solid, yield 55.7percent.
Mp 214-216 °C. 1H NMR (300 MHz, CDCl3), δ (ppm): 8.21 (s, 1H), 5.95 (s, 1H), 4.37 (q, J = 7.0 Hz, 2H), 1.34 (t, J = 7.0 Hz, 3H). MS (ESI+) m/z: 184 [M+H]+.
50%
Stage #1: at 120℃; for 2 h;
Stage #2: With ammonia In water at 20℃; for 0.5 h;
A mixture of 5.0 g (24.73 mmol) diethyl 1,3-acetonedicarboxylate, 5.05 g (49.45 mmol) acetic anhydride and 3.7 g (24.73 mmol) ethyl orthoformate was heated to 12O0C for 2 hours. Volatile components were removed under reduced pressure and the remaining mixture was treated with 10 ml of aqueous ammonia (25percent). The mixture was stirred for 30 minutes at room temperature. Subsequently the pH of the mixture was adjust to pH 2 with aqueous HCl (2N). The solid was filtered off, washed with cold water and dried. 8 ml of toluene were added to the crude product, the mixture was stirred at O0C for 30 minutes and then filtered and dried to give 2.26 g (50percent) of a red solid. 1H-NMR (DMSOd6): 11.77 (s, br, IH); 10.74 (s, br, IH); 8.01 (s, IH); 5.60 (s, IH); 4.26 (q, 2H); 1.28 (t, 3H).
50%
Stage #1: at 120℃; for 2 h;
Stage #2: at 20℃; for 0.5 h;
G] Preparation of compound 5 -G A mixture of 5.0 g (24.73 mmol) diethyl 1,3-acetonedicarboxylate, 5.05 g (49.45 mmol) acetic anhydride and 3.7 g (24.73 mmol) ethyl orthoformate is heated to 1200C for 2 hours. Volatile components are removed under reduced pressure and the remaining mixture is treated with 10 ml of aqueous ammonia (25percent). The mixture is stirred for 30 minutes at room temperature. Subsequently the pH of the mixture is adjust to pH 2 with aqueous HCl (2N). The solid is filtered off, washed with cold water and dried. 8 ml of toluene are added to the crude product, the mixture is stirred at 00C for 30 minutes and then filtered and dried to give 2.26 g (50percent) of a red solid.1H-NMR (DMSO-de): 11.77 (s, br, IH); 10.74 (s, br, IH); 8.01 (s, IH); 5.60 (s, IH); 4.26 (q, 2H); 1.28 (t, 3H).
50%
Stage #1: at 120℃; for 2 h;
Stage #2: With ammonia In water at 20℃; for 0.5 h;
A mixture of 5.0 g (24.73 mmol) diethyl 1,3-acetonedicarboxylate, 5.05 g (49.45 mmol) acetic anhydride and 3.7 g (24.73 mmol) ethyl orthoformate was heated to 12O0C for 2 hours. Volatile components were removed under reduced pressure and the remaining mixture was treated with 10 ml of aqueous ammonia (25percent). The mixture was stirred for 30 minutes at room temperature. Subsequently the pH of the mixture was adjust to pH 2 with aqueous HCl (2N). The solid was filtered off, washed with cold water and dried. 8 ml of toluene were added to the crude product, the mixture was stirred at O0C for 30 minutes and then filtered and dried to give 2.26 g (50percent) of a red solid. 1H-NMR (DMSOd6): 11.77 (s, br, IH); 10.74 (s, br, IH); 8.01 (s, IH); 5.60 (s, IH); 4.26 (q, 2H); 1.28 (t, 3H).
22%
Stage #1: at 120℃; for 1.5 h;
Stage #2: With ammonium hydroxide In water at 0℃; for 1 h;
Stage #3: With hydrogenchloride In water
A mixture of scheme 1 compound 1 (50.0 g, 247.5 mmol), triethyl orthofomate (40.3 g, 272.3 mmol) and acetic anhydride (50.5 g, 495.0 mmol) was heated at 120 °C for 1.5h with vigorous stirring. The dark yellow solution was cooled in an ice bath, and mixed with ammonia (20 mL, 30percent water solution). The resulting mixture was stirred at 0 °C for lh. A yellow solid formed in the mixture. After the mixture was acidified with 2N HC1 to pH = 5, a white solid formed. The mixture was filtered, washed with water and air dried to give scheme 1 compound 2 (10.0 g, yield: 22.0percent) as a white solid. 1H NMR (400 MHz, MeOD): δ 8.16 (s, 1H, ArH), 5.79 (s, 1H, ArH), 4.38 (q, J= 7.2 Hz, 2H, CH2), 1.37 (t, J= 7.2 Hz, 3H, CH3).

Reference: [1] European Journal of Medicinal Chemistry, 2014, vol. 87, p. 52 - 62
[2] Antimicrobial Agents and Chemotherapy, 2016, vol. 60, # 8, p. 4442 - 4452
[3] European Journal of Organic Chemistry, 2014, vol. 2014, # 7, p. 1487 - 1495
[4] European Journal of Medicinal Chemistry, 2016, vol. 119, p. 17 - 33
[5] Tetrahedron Letters, 2011, vol. 52, # 4, p. 512 - 514
[6] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 20, p. 6551 - 6559
[7] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 3, p. 403 - 427
[8] Patent: WO2008/17696, 2008, A1, . Location in patent: Page/Page column 50-51
[9] Patent: WO2009/106419, 2009, A1, . Location in patent: Page/Page column 78
[10] Patent: WO2008/17696, 2008, A1, . Location in patent: Page/Page column 50-51
[11] Patent: WO2014/52365, 2014, A1, . Location in patent: Page/Page column 165-166
[12] Patent: WO2008/51757, 2008, A1, . Location in patent: Page/Page column 31
[13] Patent: WO2005/34869, 2005, A2, . Location in patent: Page/Page column 39
[14] Patent: WO2011/97526, 2011, A1, . Location in patent: Page/Page column 30
[15] Patent: WO2007/136465, 2007, A2, . Location in patent: Page/Page column 33
[16] Patent: WO2009/105712, 2009, A1, . Location in patent: Page/Page column 35-36
[17] Patent: WO2005/34869, 2005, A2, . Location in patent: Page/Page column 39
  • 6
  • [ 105-50-0 ]
  • [ 149-73-5 ]
  • [ 6975-44-6 ]
YieldReaction ConditionsOperation in experiment
55% With ammonia; acetic anhydride In water at 0 - 120℃; for 20 h; Inert atmosphere (E. Wallace, B. Hurley, H. W. Yang, J. Lyssikatos and J. Blake, Int. Pat. App. WO200523759, 2005): Trimethylorthoformate (5.95 mL, 54.4 mmol) was added to a solution of diethyl 1,3-acetonedicarboxylate (i) (8.98 mL, 49.5 mmol) in acetic anhydride (9.34 mL, 99.0 mmol). The reaction mixture was heated under N2(g) to 120°C for 2 h, cooled to room temperature and the excess solvent removed in vacuo. The resulting dark orange residue was cooled to 0°C and treated with an aqueous solution of ammonia (33percent, 4 mL) followed by water (15 mL). The mixture was stirred at room temperature for 18 h and the resulting heavy tan precipitate filtered, washed with water (20 mL) and air dried to give compound ii. (5.00 g, 27.3 mmol, 55percent) as a light tan solid, [M+H]+ m/z = 184.1.
55%
Stage #1: at 120℃; for 2 h; Inert atmosphere
Stage #2: With ammonia In water; acetic anhydride at 0 - 20℃; for 18 h; Inert atmosphere
Trimethylorthoformate (5.95 mL, 54.4 mmol) was added to a solution of diethyl 1,3-acetonedicarboxylate 34 (8.98 mL, 49.5 mmol) in acetic anhydride (9.34 mL, 99.0 mmol). The reaction mixture was heated under N2(g) to 120 °C for 2 h, cooled to room temperature and the excess solvent removed in vacuo. The resulting dark orange residue was cooled to 0 °C and treated with an aqueous solution of ammonia (33percent, 4 mL) followed by water (15 mL). The mixture was stirred at room temperature for 18 h and the resulting heavy tan precipitate filtered, washed with water (20 mL) and air dried to give the title compound17 (5.00 g, 27.3 mmol, 55percent) as a light tan solid, m.p. 200-204 °C (from EtOH–water, lit.18 m.p. 213 °C); Rf 0.27 (EtOAc); δH (300 MHz, DMSO-d6); 8.02 (1H, s, 2-H), 5.60 (1H, s, 5-H), 4.27 (2H, q, J 7.2, 3-CO2CH2CH3), 1.28 (3H, t, J 7.2, 3-CO2CH2CH3); δC (75 MHz, DMSO-d6); 166.4 (3-CO2CH2CH3), 166.3 (6-C), 163.9 (4-C), 143.0 (2-C), 100.4 (5-C), 98.8 (3-C), 61.2 (3-CO2CH2CH3), 14.4 (3-CO2CH2CH3); νmax/cm-1 (solid); 3053, 2689, and 1658; m/z (ES) 184.1 (100percent, MH+); (Found MH+, 184.0606. C8H9NO4 requires MH 184.0610); LC-MS; RT= 1.23min, m/z (ES+) found MH+, 184.1.
Reference: [1] Patent: WO2013/91011, 2013, A1, . Location in patent: Page/Page column 66; 67
[2] European Journal of Medicinal Chemistry, 2014, vol. 86, p. 31 - 38
[3] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 7, p. 2355 - 2361
[4] Patent: US2007/60577, 2007, A1, . Location in patent: Page/Page column 30; 43
  • 7
  • [ 108-24-7 ]
  • [ 105-50-0 ]
  • [ 6975-44-6 ]
YieldReaction ConditionsOperation in experiment
60%
Stage #1: at 120℃; for 2 h;
Stage #2: With ammonia In dichloromethane at 0 - 20℃;
3-Oxo-pentanedioic acid diethyl ester (101 g, 0.5 mmol), triethyl orthoformate (81.4 g, 0.55 mol) and acetic anhydride (102 g, 1 mol) were combined and heated to 120° C. for 2 h.
The resulting mixture was cooled to RT and dissolved in DCM (1 L).
After further cooling to 0° C., ammonia (30percent, 80 mL) was added and the reaction mixture was allowed to warm to RT overnight.
The product was extracted with water (2*) and the aqueous layer was acidified to pH 5 with conc. HCl.
The precipitate was collected by filtration to afford ethyl 4,6-dihydroxynicotinate (60.0 g, 60percent yield).
1H NMR (400 MHz, DMSO-d6): δ 7.99 (s, 1H), 5.58 (s, 1H), 4.23 (q, J=6.8, 14.0 Hz, 2H), 1.25 (t, J=7.2 Hz, 3H); MS (ESI) m/z: 184.1 [M+H]+.
Reference: [1] Patent: US8461179, 2013, B1, . Location in patent: Page/Page column 66
  • 8
  • [ 1336-21-6 ]
  • [ 122-51-0 ]
  • [ 105-50-0 ]
  • [ 6975-44-6 ]
YieldReaction ConditionsOperation in experiment
82.8%
Stage #1: at 120℃; for 3 h;
Stage #2: at 0℃; for 1 h;
Diethyl 1,3-acetonedicarboxylate (2 x 50 g, 1.0 eq, Aldrich) was added in portions to acetic anhydride (2 x 58.6 g, 2.0 eq) in a round bottomed flask. To this solution, triethyl orthoformate (2 x 51 g, 1.2 eq) was added slowly and the contents heated under a reflux condenser at 120°C for 3 h. The contents were cooled to 0°C and 25percent aqueous ammonia was added slowly while stirring. The mixture continued stirring for 1 h at 0°C and the mixture acidified with 3N HC1 solution. The solid that separated out was filtered and dried under vacuum to obtain product as white solid ethyl 4,6-dihydroxynicotinate (75.1 g, 82.8percent). LCMS: Purity: 99.84percent, MS: 184.18 (M+H).
Reference: [1] Patent: WO2015/38417, 2015, A1, . Location in patent: Page/Page column 75; 76
  • 9
  • [ 108-24-7 ]
  • [ 122-51-0 ]
  • [ 105-50-0 ]
  • [ 6975-44-6 ]
YieldReaction ConditionsOperation in experiment
60% at 120℃; for 2 h; Example C3: 3-0xo-pentanedioic acid diethyl ester (101 g, 0.5 mmol), triethylorthoformate (81.4 g, 0.55mol) and acetic anhydride (102 g, 1 mol) were combined andheated to 120°C for 2 h. The resulting mixture was cooled toRT and dissolved in DCM (1L). After further cooling to 0°C, ammonia (30percent, 80 mL) was added and the reaction mixturewas allowed to warm to RT overnight. The product was extracted with water (2x) and theaqueous layer was acidified to pH 5 with cone. HCl. The precipitate was collected byfiltration to afford ethyl 4,6-dihydroxynicotinate (60.0 g, 60percent yield). 1H NMR (400 MHz,DMSO-d6): 8 7.99 (s, 1 H), 5.58 (s, 1 H), 4.23 (q, J = 6.8, 14.0 Hz, 2 H), 1.25 (t, J = 7.2 Hz, 3H); MS (ESI) mlz: 184.1 [M+Ht.
Reference: [1] Patent: WO2013/184119, 2013, A1, . Location in patent: Paragraph 0203
  • 10
  • [ 105-50-0 ]
  • [ 6975-44-6 ]
Reference: [1] European Journal of Organic Chemistry, 2014, vol. 2014, # 7, p. 1487 - 1495
  • 11
  • [ 638-37-9 ]
  • [ 3287-99-8 ]
  • [ 105-50-0 ]
  • [ 28957-72-4 ]
Reference: [1] Patent: US2845427, 1955, ,
[2] Patent: US2836598, 1954, ,
  • 12
  • [ 105-50-0 ]
  • [ 99-32-1 ]
Reference: [1] Organic Letters, 2011, vol. 13, # 12, p. 3194 - 3197
  • 13
  • [ 150-19-6 ]
  • [ 105-50-0 ]
  • [ 62935-72-2 ]
Reference: [1] Journal of Medicinal Chemistry, 1986, vol. 29, # 6, p. 1094 - 1099
  • 14
  • [ 105-50-0 ]
  • [ 62935-72-2 ]
Reference: [1] Journal of Medicinal Chemistry, 2004, vol. 47, # 25, p. 6349 - 6362
  • 15
  • [ 105-50-0 ]
  • [ 80883-54-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2004, vol. 47, # 25, p. 6349 - 6362
[2] Journal of the Chemical Society, 1915, vol. 107, p. 1637
[3] Journal of Medicinal Chemistry, 2016, vol. 59, # 10, p. 5022 - 5034
  • 16
  • [ 105-50-0 ]
  • [ 99-07-0 ]
  • [ 80883-54-1 ]
Reference: [1] Tetrahedron, 2018, vol. 74, # 12, p. 1175 - 1183
  • 17
  • [ 17356-08-0 ]
  • [ 105-50-0 ]
  • [ 38067-29-7 ]
Reference: [1] Phosphorus, Sulfur and Silicon and Related Elements, 1998, vol. 141, p. 185 - 190
[2] Patent: WO2012/59041, 2012, A1, . Location in patent: Page/Page column 68; 69
  • 18
  • [ 105-50-0 ]
  • [ 38067-29-7 ]
Reference: [1] Journal of the American Chemical Society, 1946, vol. 68, p. 268
  • 19
  • [ 105-50-0 ]
  • [ 6317-97-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 20, p. 6551 - 6559
[2] Patent: WO2009/106419, 2009, A1,
[3] Patent: WO2008/17696, 2008, A1,
  • 20
  • [ 77-92-9 ]
  • [ 105-50-0 ]
Reference: [1] European Journal of Organic Chemistry, 2012, # 29, p. 5818 - 5827,10
[2] Gazzetta Chimica Italiana, 1891, vol. 21 I, p. 306
[3] Chemische Berichte, 1916, vol. 49, p. 2704[4] Chemische Berichte, 1920, vol. 53, p. 1917
  • 21
  • [ 64-17-5 ]
  • [ 77-92-9 ]
  • [ 105-50-0 ]
Reference: [1] European Journal of Organic Chemistry, 2012, # 29, p. 5818 - 5827
[2] Journal of Organic Chemistry, 2018,
[3] Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft, 1967, vol. 300, # 1, p. 53 - 61
  • 22
  • [ 542-05-2 ]
  • [ 64-17-5 ]
  • [ 105-50-0 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1921, vol. 422, p. 11
[2] Journal of the Chemical Society, 1922, vol. 121, p. 1644
[3] Organic Syntheses 5 &lt;New York 1925&gt;, S. 53,
[4] Journal of Organic Chemistry USSR (English Translation), 1988, vol. 24, p. 101 - 104[5] Zhurnal Organicheskoi Khimii, 1988, vol. 24, # 1, p. 116 - 119
[6] Russian Journal of Organic Chemistry, 2010, vol. 46, # 4, p. 517 - 519
  • 23
  • [ 542-05-2 ]
  • [ 105-50-0 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1921, vol. 422, p. 11
[2] Journal of the Chemical Society, 1922, vol. 121, p. 1644
[3] Chemische Berichte, 1890, vol. 23, p. 3757
[4] Journal of the American Chemical Society, 1944, vol. 66, p. 1658
[5] Bulletin des Societes Chimiques Belges, 1945, vol. 54, p. 80
[6] Organic Syntheses, Coll. Vol. I &lt;2. Ausg. 1941&gt; 237,
  • 24
  • [ 619-67-0 ]
  • [ 105-50-0 ]
Reference: [1] Patent: US6034099, 2000, A,
  • 25
  • [ 115996-74-2 ]
  • [ 105-50-0 ]
Reference: [1] Journal of Organic Chemistry USSR (English Translation), 1988, vol. 24, p. 101 - 104[2] Zhurnal Organicheskoi Khimii, 1988, vol. 24, # 1, p. 116 - 119
  • 26
  • [ 95-92-1 ]
  • [ 67-64-1 ]
  • [ 105-50-0 ]
Reference: [1] Organic Letters, 2011, vol. 13, # 12, p. 3194 - 3197
  • 27
  • [ 463-51-4 ]
  • [ 1663-67-8 ]
  • [ 105-50-0 ]
Reference: [1] Collection of Czechoslovak Chemical Communications, 1954, vol. 19, p. 1231,1236
  • 28
  • [ 64-17-5 ]
  • [ 77570-27-5 ]
  • [ 105-50-0 ]
Reference: [1] Synthesis, 1981, # 2, p. 130 - 133
  • 29
  • [ 64-17-5 ]
  • [ 5780-52-9 ]
  • [ 105-50-0 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1972, p. 3151 - 3156
  • 30
  • [ 5780-52-9 ]
  • [ 141-52-6 ]
  • [ 105-50-0 ]
Reference: [1] Comptes Rendus des Seances de l'Academie des Sciences, Serie C: Sciences Chimiques, 1966, vol. 262, p. 135 - 138
  • 31
  • [ 542-05-2 ]
  • [ 64-17-5 ]
  • [ 6202-45-5 ]
  • [ 105-50-0 ]
Reference: [1] Chemische Berichte, 1898, vol. 31, p. 2015
  • 32
  • [ 90927-60-9 ]
  • [ 105-50-0 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1964, vol. 83, p. 513 - 514
  • 33
  • [ 79353-42-7 ]
  • [ 105-50-0 ]
Reference: [1] Roczniki Chemii, vol. 6, p. 24[2] Chem. Zentralbl., 1926, vol. 97, # II, p. 2906
  • 34
  • [ 21269-49-8 ]
  • [ 105-50-0 ]
Reference: [1] Chemische Berichte, 1899, vol. 32, p. 1285
  • 35
  • [ 463-51-4 ]
  • [ 67-66-3 ]
  • [ 1663-67-8 ]
  • [ 105-50-0 ]
Reference: [1] Collection of Czechoslovak Chemical Communications, 1955, vol. 20, p. 593,595[2] Chemicke Listy, 1955, vol. 49, p. 78
[3] Collection of Czechoslovak Chemical Communications, 1955, vol. 20, p. 285,289
[4] Collection of Czechoslovak Chemical Communications, 1954, vol. 19, p. 1231,1236
  • 36
  • [ 7647-01-0 ]
  • [ 64-17-5 ]
  • [ 101875-39-2 ]
  • [ 21269-49-8 ]
  • [ 105-50-0 ]
Reference: [1] Nippon Kagaku Zasshi, 1957, vol. 78, p. 1780,1783[2] Chem.Abstr., 1960, p. 1505
  • 37
  • [ 105-50-0 ]
  • [ 109-77-3 ]
  • [ 58168-20-0 ]
YieldReaction ConditionsOperation in experiment
82%
Stage #1: With triethylamine In ethanol at 20 - 45℃; for 1 h;
Stage #2: With sulfur In ethanolReflux
Example 1 : Preparation of ethyl 5-amino-4-cvano-3-(2-ethoxy-2-oxoethyl)-2-thiophene carboxylate compound of formula HI Triethylamine (25 g) was added to a solution of malononitrile (16.33 g) and diethyl-3- oxogutarate (50 g) in ethanol (75 ml) at ambient temperature. The reaction mixture was stirred at 40-45°C for 1 hour. Sulphur (7.9 g) was added into the reaction mass and was heated to reflux till the completion of reaction. The reaction mass was cooled at ambient temperature and added water (400 ml) slowly. Stirred the reaction mixture for 1 hour and filtered the product, washed with water (200 ml) and dry the product at 40-50°C. Yield 82percent.
Reference: [1] Heteroatom Chemistry, 2007, vol. 18, # 3, p. 236 - 238
[2] Patent: WO2013/113319, 2013, A1, . Location in patent: Page/Page column 6
  • 38
  • [ 105-50-0 ]
  • [ 109-77-3 ]
  • [ 23903-46-0 ]
  • [ 58168-20-0 ]
Reference: [1] Patent: WO2011/124992, 2011, A1, . Location in patent: Page/Page column 19
  • 39
  • [ 105-50-0 ]
  • [ 58194-26-6 ]
Reference: [1] Heteroatom Chemistry, 2007, vol. 18, # 3, p. 236 - 238
[2] Patent: WO2011/124992, 2011, A1,
[3] Patent: WO2013/113319, 2013, A1,
  • 40
  • [ 105-50-0 ]
  • [ 1948-48-7 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1953, vol. 72, p. 721,72
  • 41
  • [ 2042-37-7 ]
  • [ 105-50-0 ]
  • [ 67237-76-7 ]
Reference: [1] Tetrahedron, 1982, vol. 38, # 23, p. 3479 - 3483
  • 42
  • [ 105-50-0 ]
  • [ 154012-15-4 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 20, p. 6551 - 6559
[2] Patent: WO2009/106419, 2009, A1,
[3] Patent: WO2008/17696, 2008, A1,
  • 43
  • [ 105-50-0 ]
  • [ 821791-58-6 ]
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 2, p. 441 - 444
[2] Patent: EP2930170, 2015, A1,
  • 44
  • [ 105-50-0 ]
  • [ 73998-95-5 ]
Reference: [1] Patent: WO2015/38417, 2015, A1,
  • 45
  • [ 105-50-0 ]
  • [ 679406-03-2 ]
Reference: [1] Patent: WO2014/74661, 2014, A1,
[2] Patent: WO2015/123453, 2015, A1,
[3] Patent: US2004/77653, 2004, A1,
  • 46
  • [ 105-50-0 ]
  • [ 1352925-63-3 ]
Reference: [1] Patent: WO2014/74661, 2014, A1,
[2] Patent: WO2015/123453, 2015, A1,
[3] Patent: WO2016/120403, 2016, A1,
[4] Patent: US2004/77653, 2004, A1,
  • 47
  • [ 105-50-0 ]
  • [ 846036-96-2 ]
Reference: [1] Patent: WO2014/52365, 2014, A1,
  • 48
  • [ 105-50-0 ]
  • [ 380626-81-3 ]
Reference: [1] Patent: WO2014/52365, 2014, A1,
  • 49
  • [ 105-50-0 ]
  • [ 1206979-33-0 ]
Reference: [1] Patent: WO2015/38417, 2015, A1,
[2] Patent: WO2015/38417, 2015, A1,
  • 50
  • [ 105-50-0 ]
  • [ 1060811-62-2 ]
Reference: [1] Patent: WO2015/38417, 2015, A1,
[2] Patent: WO2015/38417, 2015, A1,
  • 51
  • [ 105-50-0 ]
  • [ 1001756-21-3 ]
Reference: [1] Patent: WO2014/52365, 2014, A1,
Same Skeleton Products
Historical Records